Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases

Annals of Surgical Oncology

Volumn 13, Issue 5, 2006, Pages 651-658

  Van Duijnhoven, Fredericke H ^a   Jansen, Maarten C ^b   Junggeburt, Jan M C ^a   Van Hillegersberg, Richard ^c   Rijken, Arjen M ^d   Van Coevorden, Frits ^e   Van Der Sijp, Joost R ^f   Van Gulik, Thomas M ^b   Slooter, Gerrit D ^g   Klaase, Joost M ^h   Putter, Hein ^a   Tollenaar, Rob A E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d AMPHIA HOSPITAL   (Netherlands)

^e ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g MÁXIMA MEDICAL CENTER   (Netherlands)

^h MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Colorectal cancer; Liver metastases; Local tumor control; Radio frequency ablation

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; ELECTRODE; FEMALE; GREAT BLOOD VESSEL; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TUMOR LOCALIZATION; TUMOR NECROSIS;

ADULT; AGED; CATHETER ABLATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE;

EID: 33645895294     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.08.014     Document Type: Article

References (34)

1. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer 1996; 78:918-26.
2. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150:195-203.
3. Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189:496-502.
4. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-46.
5. Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989; 124:1021-2.
6. Bilchik AJ, Rose DM, Allegra DP, Bostick PJ, Hseuh E, Morton DL. Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am 1999; 5:356-61.
7. de Baere T, Elias D, Ducreux M, et al. Percutaneous radio-frequency of liver metastases: single center experience over a five year period (abstract). Proc Am Soc Clin Oncol 2003; 1387:345.
8. Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999; 177:303-6.
9. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90:1240-3.
10. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10:1059-69.
11. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin North Am 2003; 12:243-55.
12. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159-66.
13. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepalology 2001; 33:1124-9.
14. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004; 239:450-8.
15. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441-51.
16. de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181:695-700.
17. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89:1206-22.
18. Livraghi T, Solbiati L, Meloni MF, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach.". Cancer 2003; 97:3027-35.
19. Goldberg SN, Charboneau JW, Dodd GD III, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-45.
20. Lin DY, Wei LJ. Robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074-8.
21. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003; 28:192-7.
22. Donckier V, van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003; 84:215-23.
23. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230:1-8.
24. Machi J, Uchida S, Sumida K, et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001; 5:477-89.
25. Oshowo A, Gillams AR, Lees WR, Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol 2003; 29:244-7.
26. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203.
27. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7:593-600.
28. Sjolie E, Lango T, Ystgaard B, Tangen GA, Nagelhus Hernes TA, Marvik R. 3D ultrasound-based navigation for radiofrequency thermal ablation in the treatment of liver malignancies. Surg Endosc 2003; 17:933-8.
29. Stippel DL, Bohm S, Beckurts KT, Brochhagen HG, Holscher AH. Experimental evaluation of accuracy of radiofrequency ablation using conventional ultrasound or a third-dimension navigation tool. Langenbecks Arch Surg 2002; 387:303-8.
30. Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14:1267-74.
31. Wiersinga WJ, Jansen MC, Straatsburg IH, et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 2003; 90:306-12.
32. Arata MA, Nisenbaum HL, Clark TW, Soulen MC. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol 2001; 12:455-8.
33. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcome following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818-25.
34. Choy PY, Koea J, McCall J, et al. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned. N Z Med J 2002; 115:U128.